- Corporate Officers - T
- Trv Gp Iv, Llc
Insider Trading History of Trv Gp Iv, Llc
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Trv Gp Iv, Llc since 2019.
This trader's CIK number is 1688325.
At the time of last reporting, Trv Gp Iv, Llc was the Officer of Tango Therapeutics, Inc.. (stock ticker symbol TNGX).
Also see all insider trading activities at Tango Therapeutics, Inc..
Note that in the past
TRV GP IV, LLC also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Tango Therapeutics, Inc. (TNGX) by Trv Gp Iv, Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | TNGX | 0 | $0 | 1,402,194 | $9,828,557 | 0 | $0 |
2024 | TNGX | 0 | $0 | 2,329,900 | $23,473,721 | 0 | $0 |
Yearly summary of insider trading at Fulcrum Therapeutics, Inc. (FULC) by Trv Gp Iv, Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | FULC | 81,250 | $1,300,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Relay Therapeutics, Inc. (RLAY) by Trv Gp Iv, Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | RLAY | 0 | $0 | 5,622,394 | $232,012,208 | 0 | $0 |
Yearly summary of insider trading at Dianthus Therapeutics, Inc. /de/ (MGTA) by Trv Gp Iv, Llc
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | MGTA | 0 | $0 | 3,700,000 | $3,056,000 | 0 | $0 |
Insider trading activities at 4 companies by Trv Gp Iv, Llc:
1. Tango Therapeutics, Inc. (TNGX)
2. Fulcrum Therapeutics, Inc. (FULC)
3. Relay Therapeutics, Inc. (RLAY)
4. Dianthus Therapeutics, Inc. /de/ (MGTA)
Table 1. Insider trading of Tango Therapeutics, Inc. (TNGX) by Trv Gp Iv, Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-08-22 | TNGX | Sale | 302,194 | 7.00 | 2,115,358 |
2025-08-19 | TNGX | Sale | 1,100,000 | 7.01 | 7,713,199 |
2024-09-13 | TNGX | Sale | 67,400 | 10.53 | 709,789 |
2024-09-05 | TNGX | Sale | 75,000 | 11.56 | 867,150 |
2024-08-27 | TNGX | Sale | 25,000 | 11.55 | 288,675 |
2024-08-19 | TNGX | Sale | 150,000 | 10.09 | 1,513,950 |
2024-08-16 | TNGX | Sale | 135,000 | 9.79 | 1,321,515 |
2024-08-01 | TNGX | Sale | 40,000 | 9.80 | 392,000 |
2024-07-30 | TNGX | Sale | 95,000 | 9.80 | 931,095 |
2024-07-31 | TNGX | Sale | 100,000 | 9.93 | 993,399 |
2024-07-26 | TNGX | Sale | 50,000 | 9.84 | 491,950 |
2024-07-24 | TNGX | Sale | 200,000 | 9.82 | 1,963,200 |
2024-07-25 | TNGX | Sale | 100,599 | 9.87 | 992,811 |
2024-07-22 | TNGX | Sale | 262,740 | 9.78 | 2,570,122 |
2024-07-23 | TNGX | Sale | 125,000 | 9.79 | 1,223,375 |
2024-07-18 | TNGX | Sale | 191,490 | 9.81 | 1,878,516 |
2024-07-17 | TNGX | Sale | 550,171 | 9.79 | 5,386,174 |
2024-02-20 | TNGX | Sale | 162,500 | 12.00 | 1,950,000 |
Table 2. Insider trading of Fulcrum Therapeutics, Inc. (FULC) by Trv Gp Iv, Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-07-22 | FULC | Buy | 81,250 | 16.00 | 1,300,000 |
Table 3. Insider trading of Relay Therapeutics, Inc. (RLAY) by Trv Gp Iv, Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-01-12 | RLAY | Sale | 1,500,000 | 40.00 | 60,000,000 |
2021-01-13 | RLAY | Sale | 2,157,100 | 42.39 | 91,435,154 |
2021-01-14 | RLAY | Sale | 1,965,294 | 41.00 | 80,577,054 |
Table 4. Insider trading of Dianthus Therapeutics, Inc. /de/ (MGTA) by Trv Gp Iv, Llc
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-02-08 | MGTA | Sale | 1,500,000 | .82 | 1,230,000 |
2023-02-07 | MGTA | Sale | 2,200,000 | .83 | 1,826,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Trv Gp Iv, Llc
(Officer of Tango Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.